Unprecedented strong intrinsic chemiluminescence generation from degradation of halogenated hydroxy-quinoid pollutants by Co(II)-mediated advanced oxidation processes: The critical role of site-specific production of hydroxyl radicals

2020 ◽  
Vol 394 ◽  
pp. 125023 ◽  
Author(s):  
Li Mao ◽  
Hui-Ying Gao ◽  
Chun-Hua Huang ◽  
Li Qin ◽  
Rong Huang ◽  
...  
2016 ◽  
Vol 374 (5) ◽  
Author(s):  
Sundaram Ganesh Babu ◽  
Muthupandian Ashokkumar ◽  
Bernaurdshaw Neppolian

Author(s):  
Sundaram Ganesh Babu ◽  
Muthupandian Ashokkumar ◽  
Bernaurdshaw Neppolian

Water ◽  
2020 ◽  
Vol 12 (12) ◽  
pp. 3398 ◽  
Author(s):  
John F. Guateque-Londoño ◽  
Efraím A. Serna-Galvis ◽  
Yenny Ávila-Torres ◽  
Ricardo A. Torres-Palma

In this work, the degradation of the pharmaceutical losartan, in simulated fresh urine (which was considered because urine is the main excretion route for this compound) by sonochemistry and UVC/H2O2 individually, was studied. Initially, special attention was paid to the degrading action of the processes. Then, theoretical analyses on Fukui function indices, to determine electron-rich regions on the pharmaceutical susceptible to attacks by the hydroxyl radical, were performed. Afterward, the ability of the processes to mineralize losartan and remove the phyto-toxicity was tested. It was found that in the sonochemical treatment, hydroxyl radicals played the main degrading role. In turn, in UVC/H2O2, both the light and hydroxyl radical eliminated the target contaminant. The sonochemical system showed the lowest interference for the elimination of losartan in the fresh urine. It was established that atoms in the imidazole of the contaminant were the moieties most prone to primary transformations by radicals. This was coincident with the initial degradation products coming from the processes action. Although both processes exhibited low mineralizing ability toward losartan, the sonochemical treatment converted losartan into nonphytotoxic products. This research presents relevant results on the elimination of a representative pharmaceutical in fresh urine by two advanced oxidation processes.


2019 ◽  
Vol 53 (4) ◽  
pp. 2054-2062 ◽  
Author(s):  
Zhihao Chen ◽  
Xuchun Li ◽  
Shujuan Zhang ◽  
Jiyuan Jin ◽  
Xiaojie Song ◽  
...  

2019 ◽  
Vol 359 ◽  
pp. 1427-1435 ◽  
Author(s):  
I.A. Vasiliadou ◽  
R. Molina ◽  
M.I. Pariente ◽  
K.C. Christoforidis ◽  
F. Martinez ◽  
...  

2015 ◽  
Vol 17 (17) ◽  
pp. 11796-11812 ◽  
Author(s):  
Daisuke Minakata ◽  
Weihua Song ◽  
Stephen P. Mezyk ◽  
William J. Cooper

In this study, we shed light on the initial addition of hydroxyl radicals (HO˙) to multiple carboxylated and hydroxylated benzene compounds in aqueous-phase advanced oxidation processes (AOPs).


Sign in / Sign up

Export Citation Format

Share Document